Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II–IIIA NSCLC patients
Sign Up to like & getrecommendations! Published in 2022 at "Molecular Oncology"
DOI: 10.1002/1878-0261.13267
Abstract: Stage II–IIIA nonsmall cell lung cancer (NSCLC) patients receive adjuvant chemotherapy after surgery as standard‐of‐care treatment, even though only approximately 5.8% of patients will benefit. Identifying patients with minimal residual disease (MRD) after surgery using… read more here.
Keywords: nsclc patients; stage iiia; detection; length analysis ... See more keywords
Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-017-3659-7
Abstract: ObjectivesStage IIIA non-small cell lung cancer (NSCLC) is heterogeneous in tumor burden, and its treatment is variable. Whole-body metabolic tumor volume (MTVWB) has been shown to be an independent prognostic index for overall survival (OS).… read more here.
Keywords: stage iiia; risk; iiia patients; mtvwb ... See more keywords
Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II-IIIA (8th edition TNM classification) primary lung cancer after curative surgery.
Sign Up to like & getrecommendations! Published in 2021 at "Lung cancer"
DOI: 10.1016/j.lungcan.2021.11.002
Abstract: OBJECTIVES This retrospective study aimed to elucidate the effect of epidermal growth factor receptor (EGFR) gene mutations on the prognosis of patients with pathological stage II-IIIA primary lung cancer after curative surgery. MATERIALS AND METHODS… read more here.
Keywords: cancer; stage iiia; patients stage; lung cancer ... See more keywords
Treat Now or Treat Later: Comparative Effectiveness of Adjuvant Therapy in Resected Stage IIIA Melanoma.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the American College of Surgeons"
DOI: 10.1097/xcs.0000000000000088
Abstract: BACKGROUND Adjuvant therapy for most sentinel-node-positive (stage IIIA) melanoma may have limited clinical benefit for older patients given the competing risk of non-cancer death. The objective of this study is to model the clinical effect… read more here.
Keywords: melanoma; therapy; age; adjuvant therapy ... See more keywords
Conditional survival in patients with stage IB‐IIIA melanoma undergoing sentinel node biopsy in Queensland: A longitudinal study
Sign Up to like & getrecommendations! Published in 2023 at "Australasian Journal of Dermatology"
DOI: 10.1111/ajd.13974
Abstract: Tumour characteristics such as thickness and ulceration, along with sentinel lymph node (SLN) status, have been essential in predicting survival in patients with locally invasive melanomas at the time of diagnosis. It is unclear if… read more here.
Keywords: conditional survival; melanoma undergoing; patients stage; stage iiia ... See more keywords
Adjuvant atezolizumab in Japanese patients with resected stage IB‐IIIA non‐small cell lung cancer (IMpower010)
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Science"
DOI: 10.1111/cas.15564
Abstract: The global phase 3 IMpower010 study evaluated adjuvant atezolizumab versus best supportive care (BSC) following platinum‐based chemotherapy in patients with resected stage IB–IIIA non‐small cell lung cancer (NSCLC). Here, we report a subgroup analysis in… read more here.
Keywords: atezolizumab bsc; stage iiia; stage; adjuvant atezolizumab ... See more keywords
Validation of the 2021 FIGO staging schema for advanced vulvar cancer
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2021-003168
Abstract: Objective The International Federation of Gynecology and Obstetrics (FIGO) revised the vulvar cancer staging schema in 2021. Previous stage IIIA–B diseases were reclassified based on nodal size (≤5 mm for stage IIIA compared with >5… read more here.
Keywords: staging schema; 2021 figo; stage iiia; stage ... See more keywords
Operative versus Nonoperative Treatment in Patients with Advanced Non-Small-Cell Lung Cancer: Recommended for Surgery
Sign Up to like & getrecommendations! Published in 2023 at "Canadian Respiratory Journal"
DOI: 10.1155/2023/4119541
Abstract: Background There is currently limited evidence for a correlation between the recommended operation and overall survival (OS) in patients with advanced non-small-cell lung cancer (NSCLC). Methods NSCLC patients with stages III and IV, recommended for… read more here.
Keywords: operation; group; stage iiia; stage ... See more keywords
Mid-term follow-up results of gradual capitate lengthening for the treatment of stage IIIA Kienbock’s disease
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Orthopaedic Surgery"
DOI: 10.1177/10225536231166205
Abstract: Purpose This study aimed to evaluate the mid–term radiological and clinical results of gradual lengthening of capitate for the treatment of stage IIIA Kienbock’s disease. Methods We retrospectively reviewed nine patients (five females, four males)… read more here.
Keywords: stage iiia; iiia kienbock; kienbock disease;
Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cardiothoracic Surgery"
DOI: 10.1186/s13019-018-0829-z
Abstract: IntroductionAdvanced non-small cell lung cancer (NSCLC) is still a therapeutic challenge as the 5-year survival is under 30%. The optimal treatment regimen is still under debate.HypothesisNeo adjuvant (NA) treatment given pre-pneumonectomy does not increase surgical… read more here.
Keywords: stage iiia; complexity; long term; treatment ... See more keywords
Cause of death among patients with non-small cell lung cancer treated with postoperative radiation therapy (PORT).
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e20555
Abstract: e20555 Background: The indications for post-operative radiation therapy (PORT) in locally advanced non-small cell lung cancer (NSCLC) remain undefined and a major concern is the perceived risk of increased mortality from cardiopulmonary causes. The purpose… read more here.
Keywords: port; stage iiia; lung cancer; cancer ... See more keywords